𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Correlates of human herpes virus-8 and herpes simplex virus type 2 infections in Northern Cameroon

✍ Scribed by A. Volpi; L. Sarmati; B. Suligoi; M. Montano; G. Rezza; M. Andreoni


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
87 KB
Volume
74
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The association between sexual activity and human herpes virus‐8 (HHV‐8) infection has been established, but the mode of acquisition is still unclear. Blood samples from 238 individuals from Northern Cameroon were tested to evaluate the incidence of herpes simplex virus‐2 (HSV‐2), human immunodeficiency virus (HIV), Treponema pallidum, and HHV‐8 infections and to identify their possible association. The presence of HSV‐2 antibodies was associated significantly with gender, age, and HIV, HHV‐8 antilatent, and T. pallidum antibodies, but not with HHV‐8 antilytic antibodies. In a multivariate model older age, female gender, seropositivity for HIV, for HHV‐8 latent antigens and for T. pallidum were associated independently with seropositivity for HSV‐2. HSV‐2‐seropositive individuals had significantly higher titers of antibodies to both lytic (P = 0.019) and latent (P = 0.021) HHV‐8 antigens. These results suggest that HSV‐2 infection can contribute to sexual transmission of HHV‐8 infection. J. Med. Virol. 74:467–472, 2004. © 2004 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Interferon lambda inhibits herpes simple
✍ Jieliang Li; Shuxian Hu; Lin Zhou; Li Ye; Xu Wang; Jie Ho; Wenzhe Ho 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB

## Abstract Herpes simplex virus Type I (HSV‐1) is a neurotropic virus that is capable of infecting not only neurons, but also microglia and astrocytes and can establish latent infection in the central nervous system (CNS). We investigated whether IFN lambda (IFN‐λ), a newly identified member of IF

Evaluation of mixed infection cases with
✍ Hisatoshi Kaneko; Takashi Kawana; Ken Ishioka; Shigeaki Ohno; Koki Aoki; Tatsuo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

## Abstract Herpes simplex virus type 1 (HSV‐1) is isolated principally from the upper half of the body innervated by the trigeminal ganglia whereas herpes simplex virus type 2 (HSV‐2) is generally isolated from the lower half of the body innervated by the sacral ganglia. However, recent reports su

AG-4 complement-fixing antibodies in cer
✍ M. Arsenakis; G. M. Georgiou; J. K. Welsh; M. N. Cauchi; J. T. May 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 French ⚖ 455 KB

## Abstract The incidence of anti‐AG‐4 complement‐fixing antibodies in Australian cervical carcinoma (CaCx), herpes simplex virus (HSV) type 1 and 2, and control patients, was investigated using local HSV strains. The local HSV strains (both HSV‐1Ml and HSV‐2Ml) were found, by neutralization experi

Quantitation of viral load in neonatal h
✍ Hiroshi Kimura; Yoshinori Ito; Masahide Futamura; Yoshihiro Ando; Yumi Yabuta; Y 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

## Abstract Neonatal herpes simplex virus (HSV) infection is a severe disease with high mortality and morbidity in spite of the development of effective anti‐viral therapies. The viral load in neonatal herpes simplex virus (HSV) infection was measured retrospectively in 37 patients. HSV DNA copy nu

A fas gene polymorphism influences herpe
✍ Koushik Chatterjee; Collet Dandara; Ulf Gyllensten; Lize van der Merwe; Ushma Ga 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

## Abstract Herpes simplex virus type 2 (HSV‐2) is a common sexually transmitted infection (STI) worldwide that causes genital infection. Among several factors responsible, host genetic factors may play an important role in susceptibility to HSV‐2 infection. Apoptosis is a vital mechanism in elimin

Reduction of herpes simplex virus-type 2
✍ Joseph J. Tumilowicz; Mildred A. Latlief 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB

## Abstract The effect of urea on plaque formation by herpes simplex virus type 2 (HSV‐2) was examined in two systems at concentrations within or approximating the range found in human urine. Approximately 7‐10 mg urea/ml, added 2, 4, or 8 hours after infection, reduced plaque formation by 50% in A